Lenvatinib Plus Anti-Pd-1 Antibody Combination Treatment Activates CD8(+) T Cells Through Reduction of Tumor-Associated Macrophage and Activation of the Interferon Pathway
PLOS ONE(2019)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined